ZAMBELLI, STEFANIA
 Distribuzione geografica
Continente #
EU - Europa 315
AS - Asia 172
NA - Nord America 170
SA - Sud America 20
AF - Africa 2
Totale 679
Nazione #
RU - Federazione Russa 175
US - Stati Uniti d'America 161
IT - Italia 83
CN - Cina 64
SG - Singapore 61
HK - Hong Kong 18
BR - Brasile 15
VN - Vietnam 15
DE - Germania 11
FI - Finlandia 11
GB - Regno Unito 11
CA - Canada 6
FR - Francia 6
NL - Olanda 6
BD - Bangladesh 4
IN - India 4
PL - Polonia 4
SE - Svezia 4
AR - Argentina 2
MX - Messico 2
ZA - Sudafrica 2
AT - Austria 1
CH - Svizzera 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
PR - Porto Rico 1
PY - Paraguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 679
Città #
Singapore 36
Moscow 34
Ashburn 23
Hong Kong 18
Milan 18
San Jose 18
Shanghai 13
Beijing 10
New York 10
Los Angeles 9
Boardman 8
Dallas 8
Ho Chi Minh City 7
Council Bluffs 6
Hefei 6
Helsinki 6
Santa Clara 6
Lappeenranta 5
Lauterbourg 5
Poplar 5
Denver 4
Hanoi 4
Warsaw 4
Cesano Boscone 3
Chennai 3
Cornaredo 3
Costa de' Nobili 3
Nuremberg 3
Orem 3
Rome 3
São Paulo 3
Amsterdam 2
Atlanta 2
Bari 2
Cagliari 2
Falkenstein 2
Fucecchio 2
Guangzhou 2
Johannesburg 2
Livorno 2
Manchester 2
Montreal 2
Naples 2
Perego 2
Phoenix 2
Pisa 2
Stezzano 2
Toronto 2
Vĩnh Long 2
Amman 1
Annapolis 1
Arezzo 1
Asunción 1
Bandaragama 1
Bologna 1
Boston 1
Brooklyn 1
Budapest 1
Byblos 1
Changsha 1
City of London 1
Clarksburg 1
Cleveland 1
Clorinda 1
Coruripe 1
Curitiba 1
Dhaka 1
Esperança 1
Extrema 1
Ferraz de Vasconcelos 1
Figino 1
Geneva 1
Georgetown 1
Greely 1
Hoshiārpur 1
Jacksonville 1
Jiaxing 1
Kassel 1
La Spezia 1
Lanham 1
Lanzhou 1
Lawrence 1
Llavallol 1
London 1
Messina 1
Mexico City 1
Motta Sant'Anastasia 1
Nova Hartz 1
Ottawa 1
Palosco 1
Parnaíba 1
Pittsburgh 1
Portsmouth 1
Princeton 1
Querétaro 1
Quận Bốn 1
Rimini 1
Río Grande 1
San Antonio 1
San Francisco 1
Totale 374
Nome #
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice 148
Spatial predictors of immunotherapy response in triple-negative breast cancer 118
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study 96
Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers 89
Modulation of the estrogen/erbB2 receptors crosstalk by CDK4/6 inhibition triggers sustained senescence in estrogen receptor and erbB2 positive breast cancer 85
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer 78
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies 46
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer 29
Development and validation of a gene expression-based Breast Cancer Purity Score 15
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practice 2
Totale 706
Categoria #
all - tutte 2.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.578


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 1 1 0 0
2022/20238 2 2 0 0 0 0 0 1 0 0 0 3
2023/202425 0 0 3 3 1 0 0 1 0 2 4 11
2024/2025168 21 11 4 11 19 17 20 31 7 4 7 16
2025/2026503 27 22 9 63 61 26 53 51 167 24 0 0
Totale 706